Breast cancer antigens

Details Breast cancer antigens Breast cancer antigens

1980-07-11

1983-05-17

Nucker, Christine M.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

Molecular bilayer structure

260112R, 260112B, 424 85, 424 88, 436543, 436545, 436542, G01N 3358, G01N 3360, C07G 700, A61K 4300

Patent

active

043839851

ABSTRACT:
Tumor associated antigens are disclosed in both crude and pure form which are specific to human breast cancer. The antigens are designated BCA. Antisera, radiolabeled antigens and antisera, as well as methods for the detection of circulating BCA are also disclosed. Methods for the extraction of BCA also form part of the invention. A diagnostic kit for the detection of circulating BCA, especially one suitable for use in as radioimmunoassay is also disclosed.

REFERENCES:
patent: 3410839 (1968-11-01), De Carvallto
patent: 3823126 (1974-07-01), Bjorklund
patent: 3956258 (1976-05-01), Hansen
patent: 3960827 (1976-06-01), Bjorklund
patent: 4132769 (1979-01-01), Osther
Chem. Abstracts, vol. 74, 1971, 21345j, Taylor et al.
Chem. Abstracts, vol. 86, 1977, 104321a, Bartorelli et al.
Clinical Chemistry, 22/6, 733-738; 1243-1255, (1976), Scharpe et al.
Nature; 203, Sep. 1964, pp. 1186-1188, De Carvallto.

Affiliated with

Also associated with

Rating

Breast cancer antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Breast cancer antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Breast cancer antigens will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1566650